SCHEMBL30262038

SCHEMBL30262038

CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)O

nearest known ligand 0.62

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ F2 P00734 4/20 0.62
▸ GLP1R P43220 7/20 0.58
▸ CALCR P30988 4/20 0.57
▸ CRHR1 P34998 1/20 0.57
▸ CRHR2 Q13324 1/20 0.57
▸ PTH1R Q03431 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29649197 0.94 CALCR (0.60) F2GLP1RCALCRCRHR1CRHR2
SCHEMBL30957808 0.93 GLP1R (0.57) F2GLP1RCALCRCRHR1CRHR2
SCHEMBL30168741 0.92 GLP1R (0.61) GLP1RPTH1R
SCHEMBL30168685 0.92 GLP1R (0.61) GLP1RPTH1R
SCHEMBL30168768 0.92 GLP1R (0.61) GLP1RPTH1R
SCHEMBL31683302 0.92 CALCR (0.66) F2GLP1RCALCRCRHR1CRHR2
SCHEMBL30168773 0.92 GLP1R (0.58) GLP1RPTH1R
SCHEMBL30176480 0.92 CALCR (0.63) F2GLP1RCALCRCRHR1CRHR2
SCHEMBL29967394 0.92 GLP1R (0.65) F2GLP1RCALCRCRHR1CRHR2
SCHEMBL29922493 0.91 GLP1R (0.57) F2GLP1RCALCRCRHR1CRHR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230040544-A1 COMPOSITIONS AND METHODS FOR RESTORING AND MAINTAINING THE DYSTROPHIN-ASSOCIATED PROTEIN COMPLEX (DAPC) SAREPTA THERAPEUTICS, INC. 2023-02-09 — — US disclosed
Send feedback